Silence Therapeutics plc (SLN): Shares Outstanding

Annual figures by period end, from SEC filings.

141.70M
As of 2025-12-31
141.74M
As of 2026-06-30
+9.5%
3-year compound annual growth
2022-12-31: 107.81M2023-12-31: 118.85M2024-12-31: 141.67M2025-12-31: 141.70M141.70M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31141.70M0.0%2026-03-05, Balance as of period end
2024-12-31141.67M+19.2%2026-03-05, Balance as of period end
2023-12-31118.85M+10.2%2025-02-27, Balance as of period end
2022-12-31107.81Mn/a2025-02-27, Balance as of period end